Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 Year follow-up cohort study

BMJ

Volumn 342, Issue 7796, 2011, Pages 537-

  Kuepper, Rebecca ^a   Van Os, Jim ^a,b   Lieb, Roselind ^c,d   Wittchen, Hans Ulrich ^d,e   Höfler, Michael ^e   Henquet, Cécile ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BASEL   (Switzerland)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANNABIS ADDICTION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GERMANY; HUMAN; INCIDENCE; INJURY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SENSITIVITY ANALYSIS; SOCIAL STATUS; SYMPTOM; URBAN AREA;

ADOLESCENT; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MARIJUANA ABUSE; PSYCHOSES, SUBSTANCE-INDUCED; RISK FACTORS; RURAL HEALTH; SOCIOECONOMIC FACTORS; URBAN HEALTH; YOUNG ADULT;

EID: 79952276116     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d738     Document Type: Article

References (47)

1. Wittchen HU, Behrendt S, Hofler M, Perkonigg A, Rehm J, Lieb R, et al. A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: evidence for heterogeneity and different treatment needs. Drug Alcohol Depend 2009;102:151-7.
2. Perkonigg A, Goodwin RD, Fiedler A, Behrendt S, Beesdo K, Lieb R, et al. The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction 2008;103:439-51.
3. Wittchen HU, Frohlich C, Behrendt S, Gunther A, Rehm J, Zimmermann P, et al. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007;88(suppl 1):60-70S.
4. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affectivemental health outcomes: a systematic review. Lancet 2007;370:319-28. (Pubitemid 47094993)
5. Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002;156:319-27. (Pubitemid 34857999)
6. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005;330:11.
7. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004;184:110-7. (Pubitemid 38186851)
8. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005;19:187-94. (Pubitemid 40577224)
9. Degenhardt L, Hall W. Is cannabis use a contributory cause of psychosis? Can J Psychiatry 2006;51:556-65.
10. Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003;71:37-48. (Pubitemid 36734857)
11. Ferdinand RF, Sondeijker F, van der Ende J, Selten JP, Huizink A, Verhulst FC. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction 2005;100:612-8. (Pubitemid 40646286)
12. Lieb R, Isensee B, von Sydow K, Wittchen HU. The early developmental stages of psychopathology study (EDSP): a methodological update. Eur Addict Res 2000;6:170-82. (Pubitemid 32008817)
13. Wittchen HU, Perkonigg A, Lachner G, Nelson CB. The early developmental stages of psychopathology study (EDSP): objectives and design. Eur Addict Res 1998;4:18-27. (Pubitemid 28163791)
14. McGrath J, Welham J, Scott J, Varghese D, Degenhardt L, Hayatbakhsh MR, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry 2010;67:440-7.
15. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005;44:181-91. (Pubitemid 40873432)
16. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, van Os J. Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment. Psychol Med 2006;36:407-15. (Pubitemid 43731095)
17. Cougnard A, Marcelis M, Myin-Germeys I, De Graaf R, Vollebergh W, Krabbendam L, et al. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychol Med 2007;37:513-27. (Pubitemid 46359599)
18. Van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009;39:179-95.
19. Dominguez MD, Wichers M, Lieb R, Wittchen HU, van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull 2011;37:84-93.
20. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002;325:1199.
21. Grech A, van Os J, Jones PB, Lewis SW, Murray RM. Cannabis use and outcome of recent onset psychosis. Eur Psychiatry 2005;20:349-53. (Pubitemid 40978562)
22. Wittchen HU, Lachner G, Wunderlich U, Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-composite international diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998;33:568-78.
23. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The composite international diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988;45:1069-77.
24. Cottler LB, Helzer JE, Mager D, Spitznagel EL, Compton WM. Agreement between DSM-III and III-R substance use disorders. Drug Alcohol Depend 1991;29:17-25.
25. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross-cultural feasibility, reliability and sources of variance of the composite international diagnostic interview (CIDI). The multicentre WHO/ADAMHA field trials. Br J Psychiatry 1991;159:645-58.
26. Wittchen HU. Reliability and validity studies of the WHO - composite international diagnostic interview (CIDI): a critical review. J Psychiatr Res 1994;28:57-84.
27. Read J, van Os J, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 2005;112:330-50. (Pubitemid 41564319)
28. Krabbendam L, van Os J. Schizophrenia and urbanicity: a major environmental influence - conditional on genetic risk. Schizophr Bull 2005;31:795-9. (Pubitemid 41437771)
29. Van Os J, Krabbendam L, Myin-Germeys I, Delespaul P. The schizophrenia environment. Curr Opin Psychiatry 2005;18:141-5.
30. Fisher HL, Craig TK, Fearon P, Morgan K, Dazzan P, Lappin J, et al. Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull 2009 October 7 [epub ahead of print].
31. Polanczyk G, Moffitt TE, Arseneault L, Cannon M, Ambler A, Keefe RS, et al. Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. Arch Gen Psychiatry 2010;67:328-38.
32. Van Os J, Kenis G, Rutten B. The environment and schizophrenia. Nature 2010;468:203-12.
33. Rossler W, Riecher-Rossler A, Angst J, Murray R, Gamma A, Eich D, et al. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res 2007;92:1-14. (Pubitemid 46561217)
34. Van Rossum I, Dominguez MD, Lieb R, Wittchen HU, van Os J. Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull 2009 Sep 30 [epub ahead of print].
35. Collip D,Myin-Germeys I, Van Os J. Does the concept of sensitization provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr Bull 2008;34:220-5.
36. Myin-Germeys I, Delespaul P, van Os J. Behavioural sensitization to daily life stress in psychosis. Psychol Med 2005;35:733-41. (Pubitemid 40716437)
37. O'Daly O, Guillin O, Tsapakis E, Martinez D, Shergill S, Murray RM. Schizophrenia and substance abuse co-morbidity: a role for dopamine sensitization? J Dual Diagn 2005;1:11-40.
38. Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, Murray RM. Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol 2004;7(suppl 1):7-13S.
39. Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G. Behavioural sensitization after repeated exposure to delta 9- tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology 2001;158:259-66. (Pubitemid 33071163)
40. Cadoni C, Valentini V, Di Chiara G. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. J Neurochem2008;106: 1586-93.
41. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;2:1483-6.
42. Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002;156:319-27. (Pubitemid 34857999)
43. Genetic Risk and Outcome in Psychosis (GROUP) Investigators. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Arch Gen Psychiatry 2010 Oct 4 [epub ahead of print].
44. Keshavan M, Montrose DM, Rajarethinam R, Diwadkar V, Prasad K, Sweeney JA. Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr Res 2008;103:114-20.
45. Niemi LT, Suvisaari JM, Tuulio-Henriksson A, Lonnqvist JK. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr Res 2003;60:239-58. (Pubitemid 36184713)
46. Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001;21:1125-41. (Pubitemid 33033121)
47. Verdoux H, van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res 2002;54:59-65.